APA

de Lorenzo-Pinto A., Giménez-Manzorro Á., Rodríguez-González C. G., Ahumada-Jiménez A., Herranz-Alonso A., Marzal-Alfaro M. B. & Sanjurjo-Sáez M. (2016). Decreased INR after acenocoumarol, ombitasvir/paritaprevir/ritonavir and dasabuvir co-administration. : Journal of clinical pharmacy and therapeutics.

Chicago

de Lorenzo-Pinto A, Giménez-Manzorro Á, Rodríguez-González C G, Ahumada-Jiménez A, Herranz-Alonso A, Marzal-Alfaro M B and Sanjurjo-Sáez M. 2016. Decreased INR after acenocoumarol, ombitasvir/paritaprevir/ritonavir and dasabuvir co-administration. : Journal of clinical pharmacy and therapeutics.

Harvard

de Lorenzo-Pinto A., Giménez-Manzorro Á., Rodríguez-González C. G., Ahumada-Jiménez A., Herranz-Alonso A., Marzal-Alfaro M. B. and Sanjurjo-Sáez M. (2016). Decreased INR after acenocoumarol, ombitasvir/paritaprevir/ritonavir and dasabuvir co-administration. : Journal of clinical pharmacy and therapeutics.

MLA

de Lorenzo-Pinto A, Giménez-Manzorro Á, Rodríguez-González C G, Ahumada-Jiménez A, Herranz-Alonso A, Marzal-Alfaro M B and Sanjurjo-Sáez M. Decreased INR after acenocoumarol, ombitasvir/paritaprevir/ritonavir and dasabuvir co-administration. : Journal of clinical pharmacy and therapeutics. 2016.